| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/25/2014 | WO2014150477A1 Recombinant factor viii formulations |
| 09/25/2014 | WO2014150289A1 Compounds and uses thereof for the modulation of hemoglobin |
| 09/25/2014 | WO2014150276A1 Compounds and uses thereof for the modulation of hemoglobin |
| 09/25/2014 | WO2014150268A1 Compounds and uses thereof for the modulation of hemoglobin |
| 09/25/2014 | WO2014150258A1 Compounds and uses thereof for the modulation of hemoglobin |
| 09/25/2014 | WO2014150256A1 Compositions and methods for the modulation of hemoglobin (s) |
| 09/25/2014 | WO2014150252A1 Methods of treatment associated with the granulocyte colony-stimulating factor receptor |
| 09/25/2014 | WO2014148910A1 Fermented nutrition high in lactose with increased iron bioavailability |
| 09/25/2014 | WO2014148886A1 Fermented nutrition high in lactose with increased iron bioavailability |
| 09/25/2014 | WO2014147597A1 Aminofucoidan as a vector for fibrinolysis in thrombotic diseases |
| 09/25/2014 | US20140288266 Synthesis of Cyclosporin Analogs |
| 09/25/2014 | US20140288122 Method for inhibiting platelet aggregation |
| 09/24/2014 | EP2780322A1 Methods and compositions associated with the granulocyte colony-stimulating factor receptor |
| 09/23/2014 | US8841307 Method of using diketopiperazines and composition containing them |
| 09/23/2014 | CA2467781C Use of a monoclonal antibody specific for a red blood cell to inhibit the reticuloendothelial system for the treatment of thrombocytopenia |
| 09/18/2014 | WO2014145040A1 Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
| 09/18/2014 | WO2014145037A1 Methods and compositions for enhancing oxygen levels in tissues |
| 09/18/2014 | WO2014144450A1 Methods for treating bleeding disorders using a platelet subpopulation |
| 09/18/2014 | WO2014142127A1 Phenylxanthene derivative |
| 09/18/2014 | WO2014140186A1 Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseases |
| 09/18/2014 | WO2014139325A1 Therapeutic compounds and compositions |
| 09/18/2014 | US20140275225 Modulators of pharmacological agents |
| 09/18/2014 | US20140271637 Methods of administering anti-tnfalpha antibodies |
| 09/16/2014 | US8835653 Chlorothiophene-isoxazoles as inhibitors of coagulation factors Xa and thrombin |
| 09/16/2014 | US8835435 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 09/16/2014 | US8835407 Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same |
| 09/16/2014 | US8834858 Treatment for dyslipidemia |
| 09/16/2014 | CA2689726C Antibodies against gpi.alpha. |
| 09/16/2014 | CA2653666C Aryl-substituted heterocycles and their use |
| 09/16/2014 | CA2512147C Aqueous extract of red vine leave and use thereof for improving blood circulation |
| 09/12/2014 | WO2014138662A1 Polyphosphate-functionalized inorganic nanoparticles as hemostatic compositions and methods of use |
| 09/12/2014 | WO2014138485A1 Ex vivo production of platelets from hematopoietic stem cells and the product thereof |
| 09/12/2014 | WO2014135694A1 Treatment and prevention of remote ischemia-reperfusion injury |
| 09/12/2014 | WO2013001544A9 Anti-thrombotic compounds |
| 09/11/2014 | US20140256652 Polypeptides Involved In Immune Response |
| 09/10/2014 | EP2773347A1 Dabigatran-amidoxime acid esters as prodrugs and use thereof as pharmaceuticals |
| 09/09/2014 | US8828959 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 09/09/2014 | US8828934 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 09/09/2014 | US8828375 Expansion of haemopoietic precursors |
| 09/09/2014 | US8828358 In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide |
| 09/03/2014 | EP2772499A1 Separation of plasma proteins |
| 09/03/2014 | EP2772498A1 Polypeptides inhibiting neovascularization and uses thereof |
| 09/03/2014 | EP2772490A1 Aminoalkyl-substituted n-thienyl benzamide derivative |
| 09/03/2014 | EP2772486A1 Kinase inhibitor and method for treatment of related diseases |
| 09/03/2014 | EP2772261A1 Orally administered adsorbent |
| 09/02/2014 | US8822654 Mutated antithrombins, a process for preparing the same and their use as drugs |
| 09/02/2014 | US8822637 Somatostatin analogues |
| 09/02/2014 | US8822458 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/02/2014 | US8822417 Albumin variants |
| 09/02/2014 | US8821936 Solid pharmaceutical formulation |
| 09/02/2014 | CA2645488C Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions |
| 08/28/2014 | WO2014128465A1 2-(hetero)aryl-benzimidazole and imidazopyridine derivatives as inhibitors of asparagime emethyl transferase |
| 08/28/2014 | WO2014127479A1 Inhibition of sema3a in the prevention and treatment of ocular hyperpermeability |
| 08/27/2014 | EP2769715A2 Methods for treating autoimmune disorders, and reagents related thereto |
| 08/27/2014 | EP2768522A1 Use of sulfated glycosaminoglycans for improving the bioavailability of factor viii |
| 08/27/2014 | EP2768521A1 Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor viii |
| 08/27/2014 | EP2768520A1 Chemically and thermodynamically stable insulin analogues and improved methods for their production |
| 08/26/2014 | US8816054 Compositions and methods for enhancing coagulation Factor VIII function |
| 08/26/2014 | US8815840 Carbazole and carboline kinase inhibitors |
| 08/26/2014 | US8815832 Oxidized regenerated cellulose hemostatic powders and methods of making |
| 08/26/2014 | US8814926 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
| 08/21/2014 | WO2014125413A1 Ip receptor agonist heterocyclic compounds |
| 08/21/2014 | US20140234945 Transthyretin variants |
| 08/20/2014 | EP2767280A1 Anemia of cancer improving / prophylactic agent |
| 08/20/2014 | EP2767279A1 Erythropoietin production-promoting agent |
| 08/20/2014 | EP2767277A1 Treatment agent and/or prophylactic agent for side effects of cancer drugs |
| 08/20/2014 | EP2766347A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| 08/20/2014 | EP2766346A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| 08/20/2014 | EP2766345A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| 08/20/2014 | EP2766041A1 Combinatorial compositions and methods of treating hemoglobinopathies |
| 08/20/2014 | EP2766013A2 Method for treating thrombotic disorders using quercetin-containing compositions |
| 08/19/2014 | US8809300 Depolymerized glycosaminoglycan from Thelenota ananas and preparation method thereof |
| 08/19/2014 | US8809274 Adhesive hemostatic agent based on porcine atelocollagen and method for production thereof |
| 08/19/2014 | US8809011 HIFα hydroxylation assay |
| 08/19/2014 | US8808691 Method for treating tumors and their metastases |
| 08/19/2014 | CA2668703C Cold storage of modified platelets |
| 08/19/2014 | CA2626881C Biodegradable particle and production method thereof |
| 08/19/2014 | CA2411596C Therapeutic agents - ii |
| 08/14/2014 | WO2014100719A3 Teatrahydro- and dihydro-isoquinoline prmt5 inhibitors and uses thereof |
| 08/14/2014 | US20140227194 Preparation for Restenosis Prevention |
| 08/14/2014 | US20140227193 Preparation for Restenosis Prevention |
| 08/14/2014 | US20140227192 Preparation for Restenosis Prevention |
| 08/13/2014 | EP2765187A1 Method for producing megakaryocytes and/or platelets from pluripotent stem cells |
| 08/13/2014 | EP2763693A2 Blood coagulation factor and a derivatives, conjugates and complexes comprising the same, and use thereof |
| 08/13/2014 | CN103987706A 吡啶酮衍生物以及含有吡啶酮衍生物的药物 Pyridinone derivatives, and the drug-containing pyridone derivatives |
| 08/13/2014 | CN103987697A 作为因子xia抑制剂的取代的四氢异喹啉化合物 As the substituted tetrahydroisoquinoline compounds factor inhibitors xia |
| 08/13/2014 | CN103987696A 作为因子xia抑制剂的取代的四氢异喹啉化合物 As the substituted tetrahydroisoquinoline compounds factor inhibitors xia |
| 08/13/2014 | CN103987403A 用于治疗无效性红细胞生成的方法和组合物 Erythropoietin for the therapy methods and compositions for |
| 08/13/2014 | CN103987389A 用于具有重度肾损害的血栓栓塞患者中血栓栓塞的预防和/或治疗剂 For thromboembolism in patients with severe renal impairment have in the prevention of thromboembolism and / or therapeutic agent |
| 08/13/2014 | CN103987386A 具有有相称效果的调节活性的(rs)-2-(2-氧代-4-苯基吡咯烷-1-基)乙酰胺化合物、药物物质(变体)及其应用、其组合物(变体) With a commensurate effect modulating activity (rs) -2- (2- oxo-4-phenyl-pyrrolidin-1-yl) acetamide compound, a drug substance (variants) and its application, the composition (varying body) |
| 08/13/2014 | CN103981076A 一种山竹保健果醋及其制备方法 One kind of mangosteen health vinegar and its preparation method |
| 08/13/2014 | CN103981050A 一种葡萄干桑葚酒的制备方法 A process for producing mulberry wine raisins |
| 08/13/2014 | CN103980240A 新的羟基红花黄色素药用盐 New HSYA pharmaceutically acceptable salt thereof |
| 08/13/2014 | CN103980239A 羟基红花黄色素a钠及其生产方法和用途 HSYA a sodium and its production method and use |
| 08/13/2014 | CN103980236A 丹参多酚酸盐及其制备方法和用途 Salvianolate its preparation and use |
| 08/13/2014 | CN103977408A 整合素α<sub>M</sub>β<sub>2</sub>的拮抗剂在制备治疗血小板数量相关疾病的药物中的应用 Integrin α <sub> M </ sub> β <sub> 2 </ sub> antagonists used in the preparation of the treatment of diseases related to platelet counts in |
| 08/13/2014 | CN103977403A 治疗溶血性疾病的方法 A method of treating a hemolytic disease |
| 08/13/2014 | CN103977402A 治疗溶血性疾病的方法 A method of treating a hemolytic disease |
| 08/13/2014 | CN103977397A 一种纳豆激酶口服乳剂及其制备方法 One kind of nattokinase oral emulsions and their preparation methods |
| 08/13/2014 | CN103977391A 一种小柴胡胶囊的制备方法及应用 A preparation method and application Xiaochaihu Capsules |